-----------DRUG CONTROL POLICY-----------
Updated 31st August 2020
Click here for 2020 BDFPA drug test results
Click here for 2019 BDFPA drug test results
Click here for 2018 BDFPA drug test results
Check any medicines or prescription drugs here, to make sure you stay legal
Global Drug Reference
Click here to view the World Anti-Doping Agency's (WADA) Prohibited List
Latest anti-doping leaflets from UKAD
Factsheet ........ Advice Card......... Who's Who
SUPPLEMENTS AND SPORTS NUTRITION POLICY
The use of any supplement is at the risk of the individual. Even with the strict controls placed on labs, consider that not all labs are tested by standards agencies; there is a risk that a product may contain contamination that could result in failed CDT tests. UK Anti Doping runs the 100% ME campaign that tries to educate the athlete about what it is they want to achieve and how to support that. Its fundamental policy regarding supplements is- Identify the need, assess the risk. Informed Sport works closely with many companies to test products for contamination and the products listed on the site indicate those that are batch tested and more safe for use.
Further information regarding policy and supplement information can be found at the following:
The BDFPA is a self-financing organisation, including the funding of its drug testing programme. This programme is administered by a nationwide network of divisional sampling officers, who endeavour to conduct testing to the highest standards as approved by the IOC and WADA. We have total faith in the integrity and commitment of all our sampling officers, in the confidence that they share a common dedication to an effective testing programme and the provision of a level playing field in terms of drug-free competition. Lifters are selected for testing without fear or favour, and all are expected to comply fully with the testing process.
Drugs Control Officer Training and Toolkit:
The BDFPA will be running a Drugs Control Officers Course for all those who wish to undertake the training and for all referees who have yet to be trained in Drugs Testing procedures. The above document is a guide on how to conduct testing and is a useful reference tool following training as a BDFPA Drugs Control Officer. Additional training and understanding of the system is encouraged and individuals who are involved in the collection of samples or just who wish to familiarise themselves with the process or how to support anti-doping polices are additionally signposted to the UKAD site where the Coach Clean Course is listed - http://www.ukad.org.uk/pages/coach-clean/. When the BDFPA Powerlifting Coaching course are established the requirement to complete the Coach Clean Course will be an element of passing the course as it is a requirement from the Skills Active board to have this qualification for a Level 2 coach and above.
Click here for TUE procedures and click here for a link to WADA's website on Therapeutic Use Exemptions
Download here for a Standard Therapeutic Use Exemptions (TUE) application form
Download here for an Abbreviated Therapeutic Use Exemptions (ATUE) application form
Click here for 2017 drug test results
Click here for 2016 drug test results
Click here for 2015 drug test results
Click here for 2014 drug test results
BDFPA Drug Control Review 2013
Click here for 2013 drug test results
Click here for 2012 drug test results
Longitudinal Testing Case -BDFPA
Click here for 2011 drug test results
Click here for 2010 drug test results
Click here for pre 2010 drug test results
IMPORTANT NOTICE: PRE-WORK OUT SUPPLEMENTS
A number of lifters have tested positive in the last year for illegal stimulants. In several cases the lifters concerned were taking pre-workout supplements that claim to boost your energy. In one case the illegal stimulant, Methylhexaneamine, was not listed as an ingredient. Be very cautious about taking these pre-workout supplements. If you must take one, take one from a manufacturer that screens their products for IOC banned substances. Methylhexaneamine can also be called by any one of the following names:-
Click here for further information on pre-workout out supplements. Posted 2nd June 2012.
Important Notice: Lifters please read the following carefully.
[Posted 19/1/2010] The FDA have issued another product recall for a range of supplements due to their undeclared steroid content. It can be accessed via the following link: http://www.nelm.nhs.uk/en/NeLM-Area/News/2010---January/182/FDA-Medwatch-MuscleMaster-products-recalled-in-the-US-/
Important Notice: Lifters please read the following carefully.
[Posted 17/11/2009] IDS Sports and FDA notified consumers that five of the IDS's dietary supplement products (Bromodrol, Dual Action Grow Tabs, Grow Tabs, Mass Tabs, and Ripped Tabs TR) contain the following undeclared substances, which FDA considers to be steroids: “Madol,” “Turinabol,” “Superdrol,” and/or “Androstenedione.”
Acute liver injury is known to be a possible harmful effect of using steroid-containing products. In addition, steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
The recalled products were distributed in either black boxes containing blister packs of 60 capsules or white bottles with black labels containing 30 or 60 capsules.
Customers who have any of the products in their possession should stop using them immediately and contact their physician if they have experienced any problems that may be related to using the products. Any adverse events that may be related to use should be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program online at www.fda.gov/MedWatch/report.htm, by phone 1-800-332-1088, or by returning the postage-paid FDA form 3500 [which may be downloaded from the MedWatch "Download Forms" page] by mail [to address on the pre-addressed form] or fax [1-800-FDA-0178].
Read the MedWatch safety summary, including a link to the Press Release, at:
What major changes does the 2010 List of Prohibited Substances and Methods include compared to the 2009 List?
The List reflects the latest scientific advances.
Several of the changes to be implemented in 2010 will allow anti-doping organizations to manage a number of substances and methods in a significantly more administrative- and cost-effective way. In particular: Salbutamol
Following several years of practice and consideration of all relevant information from stakeholders and others, WADA’s List Committee recommended a change for the status of the beta-2 agonist salbutamol – a substance listed as a specified substance in the 2009 List.
Over the past few years, almost all cases where salbutamol has been detected were covered by Therapeutic Use Exemptions (TUEs).
In the 2010 List, therapeutic use of inhaled salbutamol will not be prohibited and will therefore no longer require a TUE. For monitoring purposes, athletes using inhaled salbutamol will be required to declare their use on the Doping Control Form when they are tested.
Salbutamol will still be prohibited for urinary concentrations above 1,000 nanograms per millilitre. In such cases, there will be a presumption that the substance was not taken by inhalation and the athlete will have the burden to demonstrate through a controlled pharmacokinetic study that the level found in his urine was the result of therapeutic inhaled use.
The detailed technical comments on the management of analytical results related to anabolic agents have now been moved to the revised WADA Technical Document on Minimum Required Performance Levels for Detection of Prohibited Substances. No further collections or analyses will be required in cases where the testosterone to epitestosterone (T/E) ratio is greater than 4 and an isotope ratio mass spectrometry (IRMS) test or any other reliable analytical method has not revealed evidence of exogenous administration of a prohibited substance.
What other noteworthy changes does the 2010 List include?
Pseudoephedrine will be reintroduced to the List.
Until 2003, pseudoephedrine was prohibited in sport. It has been included in WADA’s Monitoring Program annually from 2004 on. (The Monitoring Program includes substances that are not prohibited in sport but are monitored by anti-doping laboratories in order to detect patterns of misuse.)
Results of the Monitoring Program over the past five years have shown a sustained increase in samples containing pseudoephedrine. The Program indicated clear abuse of this substance with high concentrations in a number of sports and regions. In addition, available literature shows scientific evidence of the performance-enhancing effects of pseudoephedrine beyond certain doses.
Based on the results of the Monitoring Program, as well as scientific literature and results of controlled excretion studies conducted by WADA, pseudoephedrine will be prohibited above 150 micrograms per millilitre.
The 2010 List clarifies that supplemental oxygen (hyperoxia) is not prohibited.
The status of platelet-derived preparations (e.g. Platelet Rich Plasma, “blood spinning”) has been clarified. These preparations will be prohibited when administered by intramuscular route. Other routes of administration will require a declaration of use in compliance with the International Standard for TUEs.
(1) Drug abuse is strictly forbidden and the BDFPA will ban for life any member found guilty of drug abuse, subject to a right of appeal as set out in the disciplinary rules.
(2) Drug abuse is the use by, or distribution to, a sportsman or sportswoman (the competitor) of any substance defined as banned by the BDFPA.
The identification of a substance and/or metabolites of a doping class in a competitor's urine or other sample will constitute an offence. Evidence of blood doping, pharmacological, chemical or physical manipulation may also be considered an offence which may be penalized.
(3) Any member or potential member must, at any time if requested by the BDFPA Drug Control Secretary or other designated official, submit to a drug test at a moment's notice. Refusal to do so or indulging in any behaviour considered by the Disciplinary Committee to be obstructive or lacking in co-operation prior to, during or following the giving of a urine sample or any other form of drug testing, will be considered a positive test.
The BDFPA membership form which must be completed and signed by all members, includes a drug covenant clearly stating that a member agrees to do everything in his or her power to enhance and ease the practical aspects of the testing procedure. As such, a member's responsibility to co-operate does not start and end with the giving of a urine sample.
(4) Any member found guilty of advising athletes or lifters on how to abuse drugs will be banned for life.
(5) If, on analysis by a reputable body, a urine sample is found to contain a substance banned by the BDFPA, or indicates the use of any agent which the BDFPA considers as constituting drug abuse, this will be regarded as a positive test and is grounds for a life ban. Under exceptional circumstances the taking of a banned drug may be considered by the Disciplinary Committee or National Council, following an appeal, not to constitute drug abuse.
(6) Banned substances are as detailed on the International Olympic Committee (IOC)/ W.D.F.P.F. list of banned substances, contained in the BDFPA Handbook. The BDFPA reserves the right to add to or subtract from this list any substance which it feels is relevant or irrelevant to what constitutes drug abuse.
(7) In the case of out of competition drug testing, the Disciplinary Committee will decide what drugs or what dosage of any given drug, constitutes drug abuse, in consultation with an official IOC accredited drug control body. Similarly the Disciplinary Committee may decide that following an in or out of competition drug test, the taking of what may be considered an excessive amount of a non-banned substance, constitutes drug abuse.
(8) It is incumbent on all BDFPA members to check with the BPFPA Drug Control Secretary or UK Sport's 'Drug Information Database', whether any substance they may wish to ingest, is on the banned list. The use of products which can be legally purchased may in some cases, still lead to drug test failures (positive test results). Similarly, certain commercially available products described as 'nutritional supplements' may contain banned substances. Commercially available products are not exempt from the WDFPF list of banned substances.
Members are considered personally responsible for ensuring that any medications or nutritional supplements which they use do not contain substances banned by the WDFPF and BDFPA. As a general rule, a claim by a member failing a drug test that he/she did not know that they had ingested a banned substance - will not be regarded as a valid defence. Ignorance of what constitutes a banned substance will not normally be considered grounds for an appeal against a ban for a positive drug test.
(9) A list of suggested alternative medications (which do not contain banned substances) is maintained by UK Sport. Copies may be obtained from the Drug Control Secretary on request.
(10) Any lifter, official or coach found guilty of drug abuse and banned for life, will have all records, titles and performances removed retrospectively.
(11) All diabetics must inform the Drug Control Secretary of their condition so the BDFPA can test for insulin abuse. If a positive test for insulin is then recorded and the member has not informed the Drug Control Secretary, that member may be banned from the BDFPA for life. The BDFPA may also test for stimulants.
DRUG TESTING POLICY
(1) Drug testing shall be by urinalysis or any other method approved by the BDFPA, and wherever appropriate shall be conducted according to IOC/WADA/WDFPF rules and procedure.
(2) Drug testing in competitions will be conducted as required. The testing of a minimum of 10% of the total number of competitors is mandatory at National or International competitions staged by the BDFPA.
(3) Drug testing out of competition will be conducted wherever and whenever this is considered necessary, and normally without any prior warning or notice to the individual concerned. Out of competition tests conducted at divisional level will be by arrangement with the Drug Control Secretary.